openPR Logo
Press release

Opioid Withdrawal Treatment Market | Merck & Co., Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis, Sanofi N.V

09-03-2020 07:51 AM CET | Health & Medicine

Press release from: TMR Research

Opioid Withdrawal Treatment Market | Merck & Co., Inc, Teva

Opioids are drugs which are used to treat pain which is derived from opium. Prescribed opioids are used to control chronic and high amount of pain which alter the mood and produce euphoric feelings. Opioid withdrawal is a syndrome of distressing psychological and physical symptoms which occur after therapeutic discontinuation and dosage reduction of opioids. Symptoms of opioid withdrawal usually begins 8 to 10 hours after the last dose. Majority of opioid withdrawal symptoms reflects increased activity of autonomic nervous system. Opioids withdrawal symptoms includes abdominal cramping, insomnia, muscle aches and pain, vomiting and diarrhea. According to CDC, more than 42,000 people died due to intake of opioid in 2016 and 40% of all opioids overdose deaths involved prescription opioid.

Get Exclusive PDF Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3678

Opioid drugs bind to multiple opiate receptors in brain and nervous system which reduces breathing rate, heart rate and blood pressure and decreases body temperature. High dose of opioids can lead to death from cardiac and respiratory arrest. Methadone, a synthetic opioid agonist which eliminate the opioid withdrawal symptoms and relieves drug craving by acting on opioid receptors in brain. Methadone is the most effective treatment for the narcotic addiction. Drugs like Buprenorphine are used for opioid withdrawal management.

Opioid Withdrawal Treatment Market: Drivers and Restraints

The growing prevalence of chronic disease and increase consumption of opioid drugs for treating pain boosts the market of opioid withdrawal treatment market. Increased addiction of opioid drug and drawback caused by the use of opioid drug drives the market of opioid withdrawal treatment market. Increasing awareness and innovation in technologies regarding the opioid withdrawal treatment and increasing consumption of non-opioid treatment drugs spur the market of opioid withdrawal treatment. Recent FDA approval of first non-opioid treatment for management of opioid withdrawal symptoms in adults is propelling the opioid withdrawal treatment market. Lack of awareness about the use of non-opioid treatment in patients, high cost of novel pharmaceuticals hinders the growth of opioid withdrawal treatment market. Unfavorable reimbursement policies and lack of awareness among the physicians in usage of opioid treatment in developing and under developed economies restraints the growth of opioid withdrawal treatment market.

Opioid Withdrawal Treatment Market: Segmentation

Tentatively, the global opioid withdrawal treatment market can be segmented on the basis of drug type, distribution channel, and geography.

Based on drug type, the global opioid withdrawal treatment market is segmented as:

Non-steroidal anti-inflammatory drugs
Analgesics
Natural sleep supplements
Others

Based on distribution channel, the global diverticular disease therapeutics market is segmented as:

Hospital Pharmacy
Retail Pharmacies
Drug Stores
Others

Buy This Report @ https://www.tmrresearch.com/checkout?rep_id=3678<ype=S

Opioid Withdrawal Treatment Market: Overview

The global market for opioid withdrawal treatment is expected to witness moderate growth over the forecast period. Increasing research and development and advancement in technologies in the opioid withdrawal treatment market boosts the overall market. Increasing demand of outpatient rehabilitation treatment centers propel the opioid withdrawal treatment market. On the basis of drug type, non-steroidal anti-inflammatory drugs accounts for the largest revenue share in the opioid withdrawal treatment market owing to increasing demand of drugs in the opioid withdrawal treatment. On the basis of distribution channel, hospital pharmacies account for the largest share owing to increase in use of prescribed opioid withdrawal treatment drug.

Opioid Withdrawal Treatment Market: Regional Outlook

Geographically, the global opioid withdrawal treatment market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant market in the global opioid withdrawal treatment market owing to high prevalence of the chronic disease and increasing use of opioid drugs as pain killers. The opioid withdrawal treatment market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of product offerings by the key players. Europe is expected to have the second large share in the global diverticular disease therapeutics market throughout the forecast period. Latin America and Middle East & Africa accounts for the slow growth due to lack of awareness and high cost associated with opioid withdrawal treatment.

Opioid Withdrawal Treatment Market: Key Players

The global market for opioid withdrawal treatment is highly fragmented. Examples of some of the key players operating in the global opioid withdrawal treatment market are Merck & Co., Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis, Sanofi N.V, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd, Bayer AG, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

To know more about the table of contents, you can click @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=3678

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in today’s supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Withdrawal Treatment Market | Merck & Co., Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Novartis, Sanofi N.V here

News-ID: 2126885 • Views: 122

More Releases from TMR Research

Recycled Thermoplastic Market Insights By Growth, Emerging Trends And Forecast B …
Recycled Thermoplastic Market: Snapshot The demand within the global recycled thermoplastic market has been rising on account of advancements in the energy sector. The use of thermoplastics across a wide array of industries has given a thrust to the growth of the global market. Moreover, the superiority of recycled thermoplastics over thermosets has also given a strong push to the growth of the global market. There have been key advancements in
Smart Card Materials Market Projected to Witness a Double-Digit CAGR During 2028
Global Smart Card Materials Market: Snapshot The global market smart card has gained phenomenal momentum in recent years due to increasing usage of smart cards in various industries for various purposes. The growing popularity of smart cards due to the convenience they offer for identification, cashless payments, and tracking amongst other things. Proliferation of BFSI industry that has seen a constant rise in its consumer base has prompted many smart card
Taxifolin Market Dynamic Business Environment During Forecast 2018 – 2028
Taxifolin Market: Snapshot Taxifolin or dihydroquercetin is a flavonoid that acts as a potential chemopreventive agent. It helps in the regulation of genes through an ARE-dependent mechanism. Primarily, taxifolin has the properties to slow down the cell growth of ovarian cancer. It can be found across many products and beverages. Particularly, taxifolin can be found across plant-based foods such as vegetables, wine, cocoa, and fruits. Conifers such as Siberian larch and
Nafion Market Promising Growth Opportunities & Forecast 2019-2029
Nafion Market: Snapshot Nafion is a sophisticated name for sulfonated tetrafluoroethylene based fluoropolymer-copolymer. It was first discovered by Walter Grot of DuPont back in the 1960s. Nafion is a first synthetic polymer that possesses ionic properties that are known as ionomers. Nafion has unique ionic features because of the incorporation of perfluorovinyl ether groups with terminated sulfonate groups onto a PTFE backbone. Nafion can also act as a cation exchange polymer

All 5 Releases


More Releases for Opioid

Analgesics Market Driven by Growing Opioid and Non-Opioid Medicine Sales
The application of opioids for the treatment of pain due to cancer, surgery, injury and trauma makes it a bright prospect in the augmentation of analgesics market. Along with opioid drugs, non-opioid is expected to underpin the analgesics market. Prominent companies are grappling to invest in research and development to augment non-opioid drugs through the application of innovative drug delivery approaches which will help in alleviating pain for considerably longer
Opioid Induced Constipation Treatment Market: Mu-opioid Receptor Antagonists to …
Takeda Pharmaceuticals Company, Ltd., with its approved drug Amitiza, holds a majority share in the global market for opioid induced constipation treatment. In 2014 the top three players - Takeda, Valeant Pharmaceuticals International, Ltd., and Boehringer Ingelheim – operated on a collective share of 91.8% of the global market. This is a highly consolidated market but with a large scope for the prominent players to penetrate regions other than North
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in
Opioid Induced Constipation Treatment Market
Opioids are medications that work on opioid receptors in order to generate morphine-like effects. These are mainly used therapeutically to relieve pain and are often abused by individuals addicted to them. Opioids comprises opiates, a conventional name that points to drugs that are derivatives of opium, including morphine. Constipation means bowel actions that are sporadic or hard to go by. The fecal matter is often dry and hard. Some of